NEW YORK (GenomeWeb News) – CombiMatrix disclosed in a filing today with the US Securities and Exchange Commission that it has entered into a supply agreement with Illumina.
The filing offers few details of the agreement, and CombiMatrix officials were unavailable for comment by the time this article was published.
The Mukilteo, Wash.-based firm said that it has agreed to sell to Illumina certain CombiMatrix products for use in or sale with Illumina products and applications. The deal is subject to certain minimum purchase order commitments, and Illumina has an option to purchase exclusive rights to use and sell those CombiMatrix products in a designated field, according to the filing.
A few weeks ago, CombiMatrix said that it had hired investment bank Robert W. Baird as a financial and strategic advisor to help the firm review "certain strategies aimed at unlocking shareholder value and creating synergistic relationships."